Sorrento Therapeutics, Inc.
10% Owner
Sorrento Therapeutics, Inc.10% Owner
Sorrento Therapeutics, Inc. insider trades: Celularity (CELU) SEC Form 4 filings
10% Owner, Celularity 8 Form 4 filings
8
Form 4 filings
last Oct 5, 2023
7
Other transactions
filings
2
Companies
Companies
Where Sorrento Therapeutics, Inc. reports to the SEC
About Sorrento Therapeutics, Inc.'s insider trades
Sorrento Therapeutics, Inc. is a 10% owner of Celularity (CELU). It has not reported an open-market purchase or sale.
Its filings also include other transactions (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CELU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.